Ribosomal protein L23a pseudogene 81 (RPL23AP81)

RPL23AP81 (Ribosomal protein L23a pseudogene 81) is a processed pseudogene in the human genome, meaning it is a region of DNA similar to the ribosomal protein L23a gene but generally non-functional (does not encode a functional protein)[1][6][7][8]. As with other pseudogenes, it likely arose via duplication and retrotransposition of the functional RPL23A gene, but it lacks the necessary regulatory elements or coding sequence integrity to produce a working protein. There are no direct reports of regulatory, structural, or pathological functions associated with RPL23AP81 specifically. The canonical ribosomal protein L23a (RPL23A) itself is a component of the large ribosomal 60S subunit and is involved in protein translation, but relevance of RPL23AP81 is limited to gene annotation and genomic studies rather than functional biology or drug targeting[1][5][7][8]. Notes on validity: - This target is misspecified for therapeutic or biomarker studies: RPL23AP81 is not a receptor, enzyme, transporter, or any canonical drug target class[1][6][7][8]. It is a pseudogene with no recognized biological role or disease association. - Information about other related pseudogenes (e.g., RPL23AP53) must not be conflated with RPL23AP81 for therapeutic or diagnostic purposes[3]. Summary conventions: - Correct capitalization and nomenclature used. - RPL23AP81 should not be considered a therapeutic target. - Return "true" for "is_incorrect" because the target is not valid for therapeutic, mechanistic, or biomarker investigation.

Other names

RPL23AP81RPL23A_40_1702RPL23A pseudogene 81

None. No drugs or therapeutic agents act on RPL23AP81.